SonoThera is a Biotech company based in South San Francisco. It has raised $215M in total funding. Latest round: Series B.
SonoThera funding overview
SonoThera is a Biotech company based in South San Francisco. SonoThera has raised $215M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2026. The round record for SonoThera runs through 2026; nothing later has been disclosed. Investors on record include Foothill Ventures, ARK Invest, VIDA Ventures, Cure Duchenne, Otsuka, UCB Ventures and 12 others. 18 distinct backers are named across the disclosed rounds.
SonoThera at a glance
Total raised
$215M
Latest round
Series B
Latest round date
June 2026
Industry
Biotech
Headquarters
South San Francisco
Notable investors
Foothill Ventures, ARK Invest, VIDA Ventures, Cure Duchenne, Otsuka, UCB Ventures, SymBiosis, Vivo Capital
Frequently asked about SonoThera funding
How much has SonoThera raised?
SonoThera has raised $215M in total disclosed funding across the rounds on record.
Who has invested in SonoThera?
Foothill Ventures, ARK Invest, VIDA Ventures, Cure Duchenne, Otsuka, UCB Ventures are named among the investors backing SonoThera.
What was the latest SonoThera funding round?
The most recent disclosed round is a Series B, announced in June 2026.
Where is SonoThera based?
SonoThera is based in South San Francisco.
What sector does SonoThera operate in?
SonoThera is tracked under Biotech from South San Francisco, with $215M in disclosed funding.
When did SonoThera last raise?
The last disclosed SonoThera round closed in June 2026 at Series B.
We update the SonoThera record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in South San Francisco and their backers are listed below.
